A network-based, integrative study to identify core biological pathways that drive breast cancer clinical subtypes

B. Dutta, L. Pusztai, Y. Qi, F. André, V. Lazar, G. Bianchini, N. Ueno, R. Agarwal, B. Wang, C. Y. Shiang, G. N. Hortobagyi, G. B. Mills, W. F. Symmans, G. Balázsi

Research output: Contribution to journalArticle

Abstract

Background: The rapid collection of diverse genome-scale data raises the urgent need to integrate and utilise these resources for biological discovery or biomedical applications. For example, diverse transcriptomic and gene copy number variation data are currently collected for various cancers, but relatively few current methods are capable to utilise the emerging information.Methods:We developed and tested a data-integration method to identify gene networks that drive the biology of breast cancer clinical subtypes. The method simultaneously overlays gene expression and gene copy number data on protein-protein interaction, transcriptional-regulatory and signalling networks by identifying coincident genomic and transcriptional disturbances in local network neighborhoods.Results:We identified distinct driver-networks for each of the three common clinical breast cancer subtypes: oestrogen receptor (ER), human epidermal growth factor receptor 2 (HER2), and triple receptor-negative breast cancers (TNBC) from patient and cell line data sets. Driver-networks inferred from independent datasets were significantly reproducible. We also confirmed the functional relevance of a subset of randomly selected driver-network members for TNBC in gene knockdown experiments in vitro. We found that TNBC driver-network members genes have increased functional specificity to TNBC cell lines and higher functional sensitivity compared with genes selected by differential expression alone.Conclusion:Clinical subtype-specific driver-networks identified through data integration are reproducible and functionally important.

Original languageEnglish
Pages (from-to)1107-1116
Number of pages10
JournalBritish Journal of Cancer
Volume106
Issue number6
DOIs
Publication statusPublished - Mar 13 2012

Fingerprint

Triple Negative Breast Neoplasms
Breast Neoplasms
Gene Dosage
Gene Regulatory Networks
Gene Knockdown Techniques
Cell Line
Neoplasm Genes
Estrogen Receptors
Proteins
Genome
Gene Expression
Genes
Neoplasms
Datasets

Keywords

  • breast cancer subtype
  • data integration
  • driver-network
  • network analysis
  • triple-negative breast cancer

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

A network-based, integrative study to identify core biological pathways that drive breast cancer clinical subtypes. / Dutta, B.; Pusztai, L.; Qi, Y.; André, F.; Lazar, V.; Bianchini, G.; Ueno, N.; Agarwal, R.; Wang, B.; Shiang, C. Y.; Hortobagyi, G. N.; Mills, G. B.; Symmans, W. F.; Balázsi, G.

In: British Journal of Cancer, Vol. 106, No. 6, 13.03.2012, p. 1107-1116.

Research output: Contribution to journalArticle

Dutta, B, Pusztai, L, Qi, Y, André, F, Lazar, V, Bianchini, G, Ueno, N, Agarwal, R, Wang, B, Shiang, CY, Hortobagyi, GN, Mills, GB, Symmans, WF & Balázsi, G 2012, 'A network-based, integrative study to identify core biological pathways that drive breast cancer clinical subtypes', British Journal of Cancer, vol. 106, no. 6, pp. 1107-1116. https://doi.org/10.1038/bjc.2011.584
Dutta, B. ; Pusztai, L. ; Qi, Y. ; André, F. ; Lazar, V. ; Bianchini, G. ; Ueno, N. ; Agarwal, R. ; Wang, B. ; Shiang, C. Y. ; Hortobagyi, G. N. ; Mills, G. B. ; Symmans, W. F. ; Balázsi, G. / A network-based, integrative study to identify core biological pathways that drive breast cancer clinical subtypes. In: British Journal of Cancer. 2012 ; Vol. 106, No. 6. pp. 1107-1116.
@article{806b294d5ed64e4dbafb584d0d266d5e,
title = "A network-based, integrative study to identify core biological pathways that drive breast cancer clinical subtypes",
abstract = "Background: The rapid collection of diverse genome-scale data raises the urgent need to integrate and utilise these resources for biological discovery or biomedical applications. For example, diverse transcriptomic and gene copy number variation data are currently collected for various cancers, but relatively few current methods are capable to utilise the emerging information.Methods:We developed and tested a data-integration method to identify gene networks that drive the biology of breast cancer clinical subtypes. The method simultaneously overlays gene expression and gene copy number data on protein-protein interaction, transcriptional-regulatory and signalling networks by identifying coincident genomic and transcriptional disturbances in local network neighborhoods.Results:We identified distinct driver-networks for each of the three common clinical breast cancer subtypes: oestrogen receptor (ER), human epidermal growth factor receptor 2 (HER2), and triple receptor-negative breast cancers (TNBC) from patient and cell line data sets. Driver-networks inferred from independent datasets were significantly reproducible. We also confirmed the functional relevance of a subset of randomly selected driver-network members for TNBC in gene knockdown experiments in vitro. We found that TNBC driver-network members genes have increased functional specificity to TNBC cell lines and higher functional sensitivity compared with genes selected by differential expression alone.Conclusion:Clinical subtype-specific driver-networks identified through data integration are reproducible and functionally important.",
keywords = "breast cancer subtype, data integration, driver-network, network analysis, triple-negative breast cancer",
author = "B. Dutta and L. Pusztai and Y. Qi and F. Andr{\'e} and V. Lazar and G. Bianchini and N. Ueno and R. Agarwal and B. Wang and Shiang, {C. Y.} and Hortobagyi, {G. N.} and Mills, {G. B.} and Symmans, {W. F.} and G. Bal{\'a}zsi",
year = "2012",
month = "3",
day = "13",
doi = "10.1038/bjc.2011.584",
language = "English",
volume = "106",
pages = "1107--1116",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - A network-based, integrative study to identify core biological pathways that drive breast cancer clinical subtypes

AU - Dutta, B.

AU - Pusztai, L.

AU - Qi, Y.

AU - André, F.

AU - Lazar, V.

AU - Bianchini, G.

AU - Ueno, N.

AU - Agarwal, R.

AU - Wang, B.

AU - Shiang, C. Y.

AU - Hortobagyi, G. N.

AU - Mills, G. B.

AU - Symmans, W. F.

AU - Balázsi, G.

PY - 2012/3/13

Y1 - 2012/3/13

N2 - Background: The rapid collection of diverse genome-scale data raises the urgent need to integrate and utilise these resources for biological discovery or biomedical applications. For example, diverse transcriptomic and gene copy number variation data are currently collected for various cancers, but relatively few current methods are capable to utilise the emerging information.Methods:We developed and tested a data-integration method to identify gene networks that drive the biology of breast cancer clinical subtypes. The method simultaneously overlays gene expression and gene copy number data on protein-protein interaction, transcriptional-regulatory and signalling networks by identifying coincident genomic and transcriptional disturbances in local network neighborhoods.Results:We identified distinct driver-networks for each of the three common clinical breast cancer subtypes: oestrogen receptor (ER), human epidermal growth factor receptor 2 (HER2), and triple receptor-negative breast cancers (TNBC) from patient and cell line data sets. Driver-networks inferred from independent datasets were significantly reproducible. We also confirmed the functional relevance of a subset of randomly selected driver-network members for TNBC in gene knockdown experiments in vitro. We found that TNBC driver-network members genes have increased functional specificity to TNBC cell lines and higher functional sensitivity compared with genes selected by differential expression alone.Conclusion:Clinical subtype-specific driver-networks identified through data integration are reproducible and functionally important.

AB - Background: The rapid collection of diverse genome-scale data raises the urgent need to integrate and utilise these resources for biological discovery or biomedical applications. For example, diverse transcriptomic and gene copy number variation data are currently collected for various cancers, but relatively few current methods are capable to utilise the emerging information.Methods:We developed and tested a data-integration method to identify gene networks that drive the biology of breast cancer clinical subtypes. The method simultaneously overlays gene expression and gene copy number data on protein-protein interaction, transcriptional-regulatory and signalling networks by identifying coincident genomic and transcriptional disturbances in local network neighborhoods.Results:We identified distinct driver-networks for each of the three common clinical breast cancer subtypes: oestrogen receptor (ER), human epidermal growth factor receptor 2 (HER2), and triple receptor-negative breast cancers (TNBC) from patient and cell line data sets. Driver-networks inferred from independent datasets were significantly reproducible. We also confirmed the functional relevance of a subset of randomly selected driver-network members for TNBC in gene knockdown experiments in vitro. We found that TNBC driver-network members genes have increased functional specificity to TNBC cell lines and higher functional sensitivity compared with genes selected by differential expression alone.Conclusion:Clinical subtype-specific driver-networks identified through data integration are reproducible and functionally important.

KW - breast cancer subtype

KW - data integration

KW - driver-network

KW - network analysis

KW - triple-negative breast cancer

UR - http://www.scopus.com/inward/record.url?scp=84862778655&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862778655&partnerID=8YFLogxK

U2 - 10.1038/bjc.2011.584

DO - 10.1038/bjc.2011.584

M3 - Article

C2 - 22343619

AN - SCOPUS:84862778655

VL - 106

SP - 1107

EP - 1116

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 6

ER -